The study aims to check whether the TUVA BX and iCover stent grafts are safe and work well when used during a specific type of minimally invasive surgery (BEVAR) to treat complex aortic aneurysms. It is a retrospective study and it is conducted at multiple hospitals and does not include a comparison group. Researchers will collect and review patient data from medical records, starting from the original procedure and continuing through the 1-year follow-up visit.
This study looks at how well a medical devices (called TUVA BX / icover stent grafts) has worked in patients who have already been treated for serious problems in the aorta (the body's main blood vessel). These problems include aneurysms, where the wall of the blood vessel becomes weak and bulges. The device is used during a type of surgery where doctors repair the blood vessel from inside the body using small tubes. These tubes (called stent grafts) help keep the blood vessel open and allow blood to flow normally. The TUVA BX / icover device is used to connect different parts of the repair. No new treatment or extra hospital visits are needed for this study. Instead, researchers will use information that has already been recorded as part of normal care. This includes details from the original treatment up to the patient's one-year check-up. The aim is to confirm that these devices are safe and work well in everyday medical practice. The study will include about 105 patients from up to 25 hospitals across Europe, the UK and Switzerland. It is expected to finish within one year, with final results planned for December 2026.
Study Type
OBSERVATIONAL
Enrollment
105
BEVAR: minimally invasive procedure used to treat complex aortic aneurysms.
Zuyderland Medisch Centrum
Heerlen, Netherlands
Freedom from re-intervention of the targeted vessel due to bridging stent complications at 1 year follow-up visit.
Freedom from re-intervention of the targeted vessel due to bridging stent complications at 1 year follow-up visit.
Time frame: 1 year
Technical Success
Technical Success defined as successful delivery and accurate placement of the TUVA/iCover devices in the intended target vessels
Time frame: Perioperative/Periprocedural
Patency
Bridging stent patency at conclusion of the procedure and at 1 year follow- up visit
Time frame: 1 year
Mortality
Aneurysm related mortality at 1 year follow-up visit.
Time frame: 1 year.
Separation of bridging stent graft
Incidence of separation of bridging stent grafts at 1 year follow-up visit as result of migration.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.